TNL Mediagene - Ordinary Shares (TNMG) Stock Price, News & Analysis

Company Overview

TNL Mediagene engages in digital advertising, integrated marketing, marketing survey, artificial intelligence technology, data analysis, content service platform, and production of audio-visual programs. It operates media, technology, and digital studio businesses primarily in Japan and Taiwan. The company was founded on May 25, 2023 and is headquartered in Taipei, Taiwan.

Key Stats

• Today's Range: $0.57 to $0.61
• 50-Day Range: $0.28 to $1.02
• 52-Week Range: $0.26 to $34.08
• Volume: 154,456 shs
• Average Volume: 2.63 million shs
• Market Capitalization: $4.03 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $3.50
• Consensus Rating: Buy

TNMG Stock Analysis - Frequently Asked Questions

How have TNMG shares performed this year?

TNL Mediagene - Ordinary Shares' stock was trading at $4.43 at the beginning of the year. Since then, TNMG shares have decreased by 86.2% and is now trading at $0.6124.
View the best growth stocks for 2025 here.

Who are TNL Mediagene - Ordinary Shares' major shareholders?

TNL Mediagene - Ordinary Shares' top institutional shareholders include Mizuho Securities Co. Ltd. (2.56%).

How do I buy shares of TNL Mediagene - Ordinary Shares?

Shares of TNMG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 6/02/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Business Services
• Industry: Holding & other investment offices
• Sub-Industry: Business Services
• Current Symbol: NASDAQ:TNMG
• CIK: 2013186
• Web: www.boacquisition.com
• Phone: 240-235-5049
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $3.50
• High Stock Price Target: $3.50
• Low Stock Price Target: $3.50
• Potential Upside/Downside: +487.2%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 1 Analysts

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $48.49 million
• Price / Sales: 0.08
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 6,586,000
• Free Float: 3,886,000
• Market Cap: $3.93 million
• Optionable: N/A
• Beta: 0.64